Can Elektrofi Acquisition Drive Halozyme's Long-Term Growth?

Key Takeaways Halozyme will acquire Elektrofi for $750M plus up to $150M in milestone payments.The deal adds Elektrofi's Hypercon technology, expanding Halozyme's delivery capabilities.HALO reaffirmed its 2025 revenue outlook, expecting $1.28B-$1.36B in total revenues.Halozyme Therapeutics (HALO) has collaboration deals related to its ENHANZE technology with large pharma companies that use the technology for the development of subcutaneous (“SC”) formulations of their various approved drugs. These deals gen ...